Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins
Open accessThe DOI matches its Crossref record.
Abstract
Although the effect of insulin-like growth factors (IGFs) in fetal adrenocortical cells has been investigated extensively, the role of the IGF system in the adult human adrenal gland remains unclear. In the present study we investigated the effect of recombinant human IGF-I and IGF-II on cortisol, dehydroepiandrosterone sulfate (DHEA-S) and cAMP synthesis in adult human adrenocortical cells in primary culture. Both IGFs stimulate basal as well as adrenocorticotropin (ACTH)-induced steroid secretion in a time- and dose-dependent fashion. While both IGFs (6.5 nM) induced only a moderate 2-fold increase in basal cortisol output after 48 h, the effect on basal DHEA-S secretion was significantly stronger, with a 2.7- and 3.7-fold stimulation by IGF-I and IGF-II respectively. Similarly, IGF-II enhanced ACTH-induced cortisol and DHEA-S secretion more potently than IGF-I. In dose-response experiments, the maximum stimulation of ACTH-induced DHEA-S secretion was induced by 1.6 nM IGF-I (2-fold increase) or IGF-II (2.9-fold increase), while the maximum response of cortisol secretion was elicited only at 13 nM IGF-I (2-fold increase) or IGF-II (2.5-fold increase). This resulted in a significant shift of the DHEA-S dose-response curves to the left, indicating a relative selective stimulation of androgen biosynthesis by physiologically low concentrations (0.4-3.2 nM) of IGF-II, and less potently by IGF-I. At all doses tested, the steroidogenic effect of IGF-II was significantly stronger than the effect of IGF-I. Although both IGF receptors are present in adult human adrenocortical cells, the steroidogenic effect of IGF-II is mediated through the IGF-I receptor, since [Arg54,55]IGF-II, which only binds to the IGF-I receptor, was equipotent with native IGF-II, whereas [Leu27]IGF-II, which preferentially binds to the type II IGF receptor, did not show any effect. In addition, [des1-3]IGF-I, which exhibits only minimal binding to IGFBPs, was significantly more potent than native IGF-I in stimulating adrenal steroid biosynthesis, and elicited almost the same maximum stimulatory effect as IGF-II and [des1-6]IGF-II. By Western ligand blotting of conditioned medium it was shown that adult human adrenocortical cells secrete various IGF-binding proteins (IGFBPs), which are induced differentially by treatment with ACTH. In conclusion, these results demonstrate that: (1)IGF-II stimulates basal as well as ACTH-induced DHEA-S and cortisol secretion from adult human adrenocortical cells more potently than IGF-I; (2) both IGFs predominantly stimulate androgen biosynthesis; (3) the steroidogenic effect of IGF-I and IGF-II is mediated through interaction with the IGF-I receptor; (4) the different steroidogenic potency of IGF-I and IGF-II might be explained by interaction of these ligands with locally produced IGFBPs. These data indicate that the IGF system plays an important role in the regulation of the differentiated function of adult human adrenocortical cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Transcriptional regulation of steroidogenic genes: StARD1, CYP11A1 and HSD3B
LaVoie, H. A., & King, S. R. (2009) · Experimental Biology and Medicine · doi:10.3181/0903-mr-97 · Cited by 261
Kolodziejczyk, B., Duleba, A. J., Spaczynski, R. Z., & Pawelczyk, L. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00501-x · Cited by 255
Clinical correlates of DHEA associated with post‐traumatic stress disorder
Yehuda, R., Brand, S. R., Golier, J. A., & Yang, R. ‐. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00801.x · Cited by 155
Charmandari, E., Hindmarsh, P. C., Johnston, A., & Brook, C. G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7522 · Cited by 134
The effects of ACTH on steroid metabolomic profiles in human adrenal cells
Xing, Y., Edwards, M. A., Ahlem, C., Kennedy, M., Cohen, A., Gomez-Sanchez, C. E., & Rainey, W. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0493 · Cited by 101
“Fottner et al. (1998) tested the stimulating effects of ACTH onlyon cortisol and DHEA-S, while Guillon et al. (1995) tested four steroids (aldosterone, corticosterone, cortisol, and 17-hydroxyprogesterone), but only after short-term ACTH treatment (2 h; Guillon et al. 1995).”
BackgroundMethodUncovering steroidopathy in women with autism: a latent class analysis
Pohl, A., Cassidy, S., Auyeung, B., & Baron-Cohen, S. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-27 · Cited by 97
“mediated by birth weight, and catch-up growth [54,55], which responds to insulin-like growth factors [56,57].”
Androgens and bone density in women with hypopituitarism.
Miller, K. K., Biller, B. M. K., Hier, J., Arena, E., & Klibanski, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8557 · Cited by 31
“of subjects 16 Type of pituitary disease Nonfunctioning adenoma 7 (44) Cushing’s disease 5 (31) Craniopharyngioma 3 (19) Prolactinoma 1 (6) Type of hormonal deficiencies Hypogonadal 10 (63) Age 50 yr 7 Mean duration amenorrhea 8.”
Background
Metadata
- Authors
- Fottner, C., Engelhardt, D., & Weber, M.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1998-09-01
- Volume
- 158
- Issue
- 3
- Pages
- 409-417
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2133953697
- Cited by
- 56
- References
- 0
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.